Search
for
Sort by
Research 19
- Cerebronal® food supplement improve status of markers ofdementia and regeneration
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- <i>De novo</i> designed bifunctional proteins for targeted protein degradation
- PROTACs: A novel strategy for cancer drug discovery and development
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Review of Drug Repositioning in Cancer Therapeutics
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer